Related Experiment Video
Updated: Nov 18, 2025

A Multiple Integrated Social Stress Model for Psychiatric Disorders in Female C57BL/6J Mice
Published on: July 15, 2025
Microbial community changes in a female rat model of Rett syndrome
A Gallucci1, K C Patterson2, A R Weit3
1Graduate Program in Translational Biology Medicine and Health, Virginia Tech, Roanoke, VA 24014, United States of America; Animal and Poultry Sciences, Virginia Polytechnic and State University, Blacksburg, VA 24061, United States of America.
This study explored the gut microbiome in a rat model of Rett syndrome (RTT), a neurodevelopmental disorder caused by MECP2 gene mutations. Researchers identified specific microbial differences linked to RTT progression, offering insights for future treatments.
Area of Science:
- Neuroscience
- Microbiology
- Genetics
Background:
- Rett syndrome (RTT) is a neurodevelopmental disorder primarily caused by mutations in the methyl-CpG-binding protein 2 (MECP2) gene.
- Disease severity and gastrointestinal issues in RTT vary, and the gut microbiome is implicated in neurodevelopmental disorders like Autism Spectrum Disorder (ASD).
- Previous studies characterized the RTT gut microbiome in humans, but the effect of MECP2 mutations in controlled animal models remained unclear.
Purpose of the Study:
- To investigate the impact of MECP2 mutations on gut microbiome composition during postnatal development in a rat model of RTT.
- To identify specific microbial taxa and developmental timepoints associated with RTT progression.
- To assess short-chain fatty acid (SCFA) levels in RTT rats compared to wild-type (WT) controls.
Main Methods:
- Utilized a zinc-finger nuclease rat model for RTT.
- Analyzed gut microbial community composition across postnatal developmental stages.
- Correlated microbial changes with the appearance and progression of behavioral symptoms.
- Measured fecal SCFA levels.
Main Results:
- Identified specific microbial taxa with differential abundance across developmental timepoints in RTT rats compared to WT rats.
- Pinpointed the p105 developmental stage as a key translational timepoint.
- Found no significant alterations in fecal SCFA levels between RTT and WT rats throughout development.
Conclusions:
- The study elucidates specific gut microbiome alterations associated with MECP2 mutations in a preclinical RTT model.
- These findings highlight developmental microbial shifts in RTT and identify a critical translational timepoint.
- The lack of SCFA alteration suggests other mechanisms may mediate gut-brain axis dysfunction in this model, contributing to translational RTT research.

